The first radio frequency identification (RFID) tag that can resist
gamma irradiation has been developed to track pharmaceutical
products early on and throughout the supply chain.
Indian pharma firm Panacea Biotec has taken a 10 percent stake in
UK-based vaccine maker Cambridge Biostability (CBL) for £1.9m
(€1.4m) under a new joint venture deal signed between the two
companies.
Millipore has introduced a new container film - PureFlex - that
ties in with the trend towards increasing use of disposable
products within the bioprocessing sector.
A US research company has published a report placing clamshell
style packaging as the forerunner in the burgeoning high visibility
packaging industry, with blister packs also on the increase.
The necessity for drug manufacturers to comply with increasingly
rigorous regulations is driving laboratory information management
systems (LIMS) growth, according a new study.
Dutch biotech company Crucell said last week that it had completed
its acquisition of SBL Vaccin in an agreement worth €39.4m, but
remained tight-lipped about its plans for the Swedish firm's
contract manufacturing business.
Singapore has successfully completed the first phase of its
biomedical science (BMS) initiative and is now pushing the second
phase forward in order to drive growth in its pharma industry
further.
Drug giant GlaxoSmithKline (GSK) has been awarded a contract with
the US government to supply 800,000 doses of flu vaccine to the US,
where a bird flu pandemic still remains a threat.
Integra Biosciences is hailing its novel cell culture system as
being responsible for dramatically transforming the effectiveness
of small-scale antibody production.
General Electric (GE) has launched a range of
ultra-high-performance plastics that it claims will answer the need
for cost-effective injection moldable resin.
It has been another few weeks of activity for the budding eClinical
industry as sponsors across the globe continue to move away from
paper toward electronic reporting in clinical trials.
The Waters Corporation and Advion Biosciences have formed an
agreement in which the two companies intend to combine products and
offer life scientists enhanced capabilities.
Germany's Vetter Pharma-Fertigung has announced its plan to expand
its services by adding vial filling for lyophilised - or
freeze-dried - products to its portfolio.
Merck Sharp & Dohme has just announced a €100m investment in
South Tipperary, Ireland to build a new formulation R&D centre
and drug manufacturing plant.
Massachusetts-based Millipore has reported a fall in net profit in
its third quarter results, mainly due to increased costs and recent
acquisition charges.
A white paper that looks at the eClinical business model strategies
has concluded that larger investments and access to multicomponent,
single-source contracting options will create more efficient models
for businesses.
The contract packaging biz is moving from an ad-hoc to a more
strategically determined, long-term approach, as pharma companies
begin to relax in the arms of service providers.
A year after it published its five-year strategy: Vision 2010 -
Building on Strengths - DSM's commitment is showing no sign of
slowing as is continues to invest in the expansion of its
pharmaceutical production capabilities around...
Although manufacturing is the most established of the pharma
outsourcing segments, many service areas are still rapidly
evolving. OutsourcingPharma.com gives a brief run down of the
current state of play.
Two new drug manufacturing facilities have been launched in global
areas that don't usually see much pharmaceutical manufacturing
activity - Bangladesh and The Gambia.
Biopharma and lifesciences firms should make use of e-learning
software solutions to relieve the burden on keeping staff updated
on regulatory and compliance training.
Using a processing technique described as "revolutionary," DSM is
accelerating its activity in the anti-infective arena and targeting
new active pharmaceutical ingredients (APIs) that it can develop
into cost-competitive...
Arkema has unveiled a new green oxidation catalyst that it claims
"makes environmental protection a priority," as well as
launching a new product website.
Firms engaging in both in-house and contract pharma manufacturing
generally display inferior performance compared to manufacturers
conducting only in-house production, according to new research.
Sigma-Aldrich Group member SAFC made its presence felt at the
recent CPhI in Paris with announcements regarding its expansion
activities in transgenic manufacturing and India.
Pfizer CentreSource has decided to outsource the manufacture of some of its active pharmaceutical ingredients (API) to two Asian contract manufacturers and intends to work with the Food and Drug Administration's (FDA) during the process.
LifeCycle has signed three collaboration agreements with big pharma
companies for the development of new anti-cholesterol products
using its novel drug delivery technologies.
Excelsyn Molecular Development claims to have made a "major
advance" in a protein intensification process that can be used to
slash the manufacturing costs of a range of amino acids.
As it looks to the "future of pharmaceuticals," Sandoz is planning
a "powerful biopharmaceuticals programme" with the construction of
a new biopharmaceuticals development centre in Ljubljana, Slovenia.
Datatrak International said it has been offered a minimum of $3m
(€2.4m) worth of contracts for next year out of a deal struck with
its first "multibillion-dollar" pharma firm in the second quarter.
Filter maker Pall Corporation has announced its plan to invest
about $50m (€63.5m) to expand its life sciences manufacturing
operations in Puerto Rico and take advantage the island's low tax
regime.
Codexis is using India as a springboard to launch it into direct
sales of high-value generic pharmaceutical intermediates, to be
sold into unregulated markets for use in patented drugs.
Rhodia was present at this year's CPhI, alerting the industry to
its latest product updates, spawned out of the market demand to
provide products that allow its customers to better address process
and handling requirements.
US drug heavyweight Pfizer is pushing through into the increasingly
profitable vaccine market with the purchase of privately held UK
firm PowderMed for an undisclosed sum.
Raylo Chemical says that it has reduced its manufacturing cycles by
up to 20 per cent and as a result saved hundreds of thousands of
dollars per year after it installed new pH sensing technology.
Dragon International Group has launched two new packaging products
developed through the use of nanotechnologies that could
potentially replace the currently used packaging on the market such
as plastic and PVC.
Cardinal Health says it is experiencing a "robust market" for its
cell line engineering technology, as it attracts the attention of
pharma giant Wyeth and executes capacity expansion plans its for
full service offerings...
Italian drug delivery technology developer Eurand has signed a $42m
(€33m) licensing deal with GlaxoSmithKline (GSK) to make a new
formulation of one of the British pharma giant's drugs.
Reaxa has chose the recent CphI to announce it is developing a new
addition to its range of scavenging resins that it claims allows a
huge reduction in product loss in the process of precious metals
clean-up.
Designed as a next generation cellulose-based virus removal filter, Planova™ S20N has demonstrated robust filtration performance for challenging molecules...
Bispecific antibodies (BisAbs), which can bind to two distinct antigens, are prone to high levels of aggregate (10-30%), challenging traditional platform...
Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...